Simplify Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Simplify Asset Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.19M	Buy	10,456 +2,520	+32%	+$1.12M	0.07%	43
2026 Q1	$3.54M	Sell	7,936 -9,556	-55%	-$4.46M	0.05%	40
2025 Q4	$7.93M	Buy	17,492 +16,267	+1,328%	+$7.01M	0.13%	26
2025 Q3	$480K	Buy	1,225 +144	+13%	+$60.2K	0.01%	102
2025 Q2	$481K	Sell	1,081 -114	-10%	-$52.5K	0.02%	76
2025 Q1	$579K	Sell	1,195 -3,494	-75%	-$1.63M	0.02%	79
2024 Q4	$1.89M	Buy	+4,689	New	+$2.17M	0.09%	53
2024 Q1	–	Sell	-2,311	Closed	-$940K	–	141
2023 Q4	$940K	Sell	2,311 -5,114	-69%	-$1.89M	0.08%	73
2023 Q3	$2.58M	Sell	7,425 -66	-0.9%	-$23.1K	0.3%	37
2023 Q2	$2.64M	Buy	+7,491	New	+$2.52M	0.35%	40
2023 Q1	–	Sell	-698	Closed	-$202K	–	134
2022 Q4	$202K	Buy	+698	New	+$213K	0.03%	75

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Simplify Asset Management's VRTX Position: Q2 2026 in Review

Simplify Asset Management increased its Vertex Pharmaceuticals (VRTX) stake by 32% in Q2 2026, buying an estimated $1.12M and bringing the position to 10,456 shares worth $5.19M. The position accounts for 0.07% of the portfolio, ranked #43.

Simplify Asset Management first reported a position in VRTX in Q4 2022 and has held it in 11 quarters since. The position peaked at $7.93M in Q4 2025. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Simplify Asset Management held 10,456 shares of Vertex Pharmaceuticals worth $5.19M as of Q2 2026.
Simplify Asset Management bought 2,520 Vertex Pharmaceuticals shares in Q2 2026, an estimated $1.12M.
Vertex Pharmaceuticals made up 0.07% of Simplify Asset Management's portfolio in Q2 2026, its #43 holding.
Simplify Asset Management first reported a position in Vertex Pharmaceuticals in Q4 2022 and has held it in 11 quarters since.
Simplify Asset Management's Vertex Pharmaceuticals position peaked at $7.93M in Q4 2025.
1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Simplify Asset Management's 13F filing for Q2 2026, filed 16 Jul 2026.